Looking for 8-10 startups to present their tech on April 12 at the 2022 MIT Health Science Technologies Conference: The Future of Cell & Gene Therapies.
This one-day event will bring together industry leaders, thought leaders, innovators and disruptors around the topic of Sustainability. We will explore sustainability and its business implications across industries from the perspective of senior corporate leaders, startup founders, investors and world class MIT faculty via keynotes, panel discussion, lightning talks and startup exhibits. Topic should appeal to a broad cross section of senior executives regardless of industry.
How should corporates set and reach their sustainability goals? What work are industry leaders doing today to decarbonize their operations, and what themes are emerging? How should we think about sustainability partnerships with competitors, government, investors and startups? Where are investors putting their capital? What problems can startups solve for corporates, and what do effective startup-corporate partnerships look like? These are just some of the questions we will address.
Join us to be part of the conversation, and to be part of the solution.
The event is jointly organized by the MIT Startup Exchange and the Industrial Liaison Program (ILP). MIT Startup Exchange actively promotes collaboration and partnerships between MIT-connected startups and industry, exclusively members of MIT's Industrial Liaison Program. “MIT-connected” startups are based on licensed MIT technology, or are founded by MIT faculty, staff, or alumni. Currently, over 1,000 startups are registered with MIT Startup Exchange.
MIT Startup Exchange is convening the workshop on May 18 at 11 AM ET to showcase top emerging MIT-connected startups from our accelerator program, STEX25.
Startup Lightning Talks presented at the 2024 MIT Tokyo Life Science Symposium.
The 2024 MIT Health Science Technology Conference will highlight broad and transformative trends in biology and healthcare, including early-stage discovery, immune cell responses, diagnostics, clinical capabilities, process development, rapid and continuous manufacturing, robotics and automation, and sustainability, all enhanced by artificial intelligence and machine learning technologies. Leading MIT researchers and MIT-connected startups will showcase these advances and discuss their implications for improving human health.
Trond Undheim, PhD, Program Director, MIT Startup Exchange; Paula Hammond, PhD, David H. Koch Professor in Engineering and Department Head, Chemical Engineering, MIT; Laura Indolfi, PhD, CEO of PanTher Therapeutics; Peter Sandor, VP, Head of Oncology Marketing Strategy, Astellas.
Rio Tinto is seeking a solution to apply a proprietary protective coating onto baked carbon anodes that are used during the production of aluminium.
Nan-Wei Gong, Cofounder & CEO, figur8
Synthetic Biology Workshop 2017 - Panel Discussion
MIT Startup Exchange is looking for 5 startups to present and exhibit at the 2025 MIT Japan Conference, to take place in Tokyo on Friday, January 24.